bioRxivImmunologyPreprint
The human small intestine contains two subsets of regulatory Foxp3+ CD4+ T cells with very different life span and functional properties.
S. K. Chauhan, R. B. Casado, O. J. B. Landsverk, H. Johannessen, D. Phung, F. Saetre, J. Jahnsen, R. Horneland, S. Yaqub, E. M. Aandahl, K. E. A. Lundin, E. S. Baekkevold, F. L. Jahnsen
Abstract
BackgroundRegulatory CD4 T cells (Tregs) in the mice gut are mainly specific for intestinal antigens and play an important role in the suppression of immune responses against harmless dietary antigens and members of the microbiota. However, information about the phenotype and function of Tregs in the human gut is limited. ObjectiveHere, we performed a detailed characterization of Foxp3+ CD4 Tregs in the human small intestine. MethodsTregs and conventional CD4 T cells derived from normal intestine as well as from transplanted duodenum and celiac disease lesions were subjected to extensive immunophenotyping and their suppressive activity and ability to produce cytokines were assessed. ResultsSmall intestinal Foxp3+ CD4 T cells were CD45RA- CD127- CTLA4+ and suppressed proliferation of autologous T cells. Approximately 60% of the Tregs expressed the transcription factor Helios. When stimulated, Helios- Tregs produced IL-17, IFN-{gamma} and IL-10, whereas Helios+ Tregs produced very low levels of these cytokines. By sampling mucosal tissue from transplanted human duodenum we demonstrated that donor Helios+ Tregs have a short life span whereas Helios- Tregs persisted for at least 1 year post-transplantation. In normal small intestine, Foxp3+ Tregs constituted only 2% of all CD4 T cells, while in active celiac disease both subsets expanded 5-10-fold. ConclusionThe small intestine contains two subsets of Tregs with different functional capacities and very different life span. Both subsets are scarce in the normal situation but increase dramatically in a chronic inflammatory setting.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CD4+ T cells persist for years in the human small intestine and mediate robust Th1 immunity.
R. Bartolome Casado, O. J. B. Landsverk, … F. L. Jahnsen·bioRxiv·Dec 3, 2019
- Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity
- HIF-1α integrates metabolic and immunoregulatory programs in RORγt⁺ regulatory T cells during intestinal inflammation
Marcella Cipelli, Eloisa M. da Silva, … Niels Olsen Saraiva Câmara·bioRxiv·Aug 19, 2026
- Antigen-specific induction of CD4+CD8αα+ intraepithelial T lymphocytes byBacteroidetes species
D. Bousbaine, P. Bhagchandani, … H. L. Ploegh·bioRxiv·Aug 5, 2020
- Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity
H. Weerakoon, J. Straube, … A. Lepletier·bioRxiv·Feb 22, 2021
- Terminal differentiation and persistence of effector regulatory T cells essential for the prevention of intestinal inflammation
S. Dikiy, A. G. Levine, … A. Y. Rudensky·bioRxiv·May 16, 2022